Reported 2 days ago
CVS Health has once again raised its 2025 earnings forecast, driven by increased prescription fill rates and an improved health insurance segment. The company's adjusted earnings are now projected to be between $6.30 and $6.40 per share, exceeding analyst expectations. Despite a drop in operating income from its pharmacy benefit management due to client price reductions, income from health insurance climbed over 39%. CVS reported a revenue growth of 8% to $98.9 billion, as its stock surged nearly 5% following the announcement.
Source: YAHOO